The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.25
Bid: 2.00
Ask: 2.50
Change: -1.25 (-35.71%)
Spread: 0.50 (25.00%)
Open: 1.875
High: 2.25
Low: 1.75
Prev. Close: 3.50
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Elixirr buys in US; JPMorgan Russian wary of values

Fri, 18th Mar 2022 20:28

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

JPMorgan Russian Securities PLC - Russia-focused investor - Net asset value per share ends Thursday at 40.3 pence. "Due to the continued closure of the Moscow Exchange (MOEX), the company considers that there has been a material change to the market value of its investments and it is in the best interests of the shareholders to apply an alternative valuation method," it adds. Continues: "While the company has applied a fair value against these investments, there is no certainty that any value will be achievable from them over the short, medium or even long term due to the factors arising following the imposition of additional sanctions against Russia."

----------

Duke Royalty Ltd - Guernsey-based royalty finance provider - Makes follow-on investment of CAD10.3 million, about GBP6.2 million, into its existing royalty partner Creo-Tech Industrial Group Inc. Creo-Tech is a Canadian holding company that acquires businesses within the engineering, procurement and construction sector in both commercial and industrial settings.

----------

Impact Healthcare REIT PLC - London-based real estate investment trust focused on healthcare properties - Invests in two care homes which were owned and operated by Woodleigh Care whose owners are retiring from the care home business. "Both homes will be operated by an existing group tenant, Welford Healthcare, and are in Mansfield, Nottinghamshire, offering 107 high quality predominantly en-suite beds, located within established residential areas," company says. Will pay GBP11.1 million for the investment, made initially by way of a loan to Welford Healthcare, which will allow it to complete the acquisition of Woodleigh Care immediately. Company adds: "The structure creates several benefits for all stakeholders, including enabling Welford Healthcare to take immediate operational control of the homes, thereby avoiding a potentially lengthy transition period while regulatory approvals are sought to register the operation of the homes in new legal entities, as well as other financial and operational efficiencies." Initial rent under the new leases is set at GBP713,750, reflecting a gross initial yield of 6.4%. Based on the homes' current trading performance, rent cover is expected to be greater than 2.0 times.

----------

Elixirr International PLC - London-based management consultancy - Acquires entire issued share capital of technology and data firm iOLAP Inc for a maximum total consideration of USD40.0 million. "The acquisition brings specialist data and analytics capabilities, including artificial intelligence and machine learning, into Elixirr where there is existing demand for these services. This will enable Elixirr to form even stronger and longer-term relationships with its existing clients as they work together on their toughest business challenges," company says. Deal consists of initial cash consideration of USD25.2 million, plus earn out payments of up to USD14.8 million. Also updates its annual outlook due to acquisition. Now guides for financial 2022 revenue in the range of GBP70 million to GBP75 million, up sharply from GBP30.3 million a year prior.

----------

CentralNic Group PLC - London-based online marketing services - Raises gross proceeds of GBP3.0 million from open offer. Issues 795,925 shares in open offer, and will now have 288.7 million shares in issue. Chief Executive Ben Crawford says: "We are grateful for the outstanding support from our institutional and retail shareholders during these challenging times. We are convinced that the proven resilience of CentralNic's businesses, built on recurring revenue models and supported by strong long term fundamental trends, will continue to drive increased shareholder value moving forward."

----------

Airea PLC - West Yorkshire-based floor coverings manufacturer - Says Chief Executive Neil Rylance will be taking a leave of absence with immediate effect due to ill health. Group Finance Director Ryan Thomas will assume the CEO role while Rylance steps aside.

----------

Genedrive PLC - Manchester-based molecular diagnostics company - Sees first six installations of the its MT-RNR1 Antibiotic Induced Hearing Loss system deployed to Manchester University NHS Foundation Trust, with four installations for Saint Mary's Hospital and two at Wythenshawe Hospital. The MT-RNR1 system screens infants in an urgent care setting for a genetic mutation that will cause lifelong hearing loss.

----------

MP Evans Group PLC - producer of palm oil in Indonesia - Notes Indonesian government increases its palm-oil export levy following the recent record-high prices. Export levy now USD200 per tonne. "The Indonesian government had recently introduced a domestic market obligation to subsidise local palm-oil supplies, but this is being withdrawn and replaced with the revised levy," company says. Also says it continues to receive strong pricing for its crude palm oil. Sees USD1,080 per tonne achieved for a tender on Friday, similar to pricing achieved just before the levy's introduction and significantly higher than the 2021 average of USD810 per tonne.

----------

MetalNRG PLC - London-based investor in natural resources and energy - Defendants in civil proceedings in English High Court requests further extension for the filing of defences. "MNRG remains focused on receipt of the defences in this case and has accordingly consented to the Defendants making the application for a further extension," company explains. Extension agreed to March 22. In January, company said it served civil legal proceedings in the English High Court against defendants - Brit ENERGY Holdings LLP, Pierpaolo Rocco and BritNRG Ltd - for a declaration and the recovery of monies paid to the LLP in 2021.

----------

W Resources PLC - London-based tin and gold mining company with projects focused in Spain and Portugal - Production at the La Parrilla mine in Spain has now restarted after maintenance shutdown on February 15. There was no production in February other than small quantities of work in progress that were reprocessed during early February. Company says: "The initial maintenance shutdown was scheduled for two weeks, and in that period further improvements were identified, delaying the restart in addition to the company evaluating options regarding the liquefied natural gas supply, following the 425% price increase announced last month."

----------

Lekoil Ltd - London-based oil and gas exploration and production company with projects focused in Nigeria and West Africa - Notes Lekoil Nigeria has suspended its decision to buy shares in Lekoil Ltd. The decision was made after Grand Court of the Cayman Islands to discharge the injunction it had previously granted against Lekoil Ltd following an application brought by Lekoil Nigeria's CEO Olalekan Akinyanmi. On December 15, Lekoil Nigeria - in which Lekoil Ltd holds a 40% interest - proposed to acquire all shares in Lekoil Ltd for 1.9 pence per share, a 100% premium to the company's trading price before its suspension on October 1.

----------

Bushveld Minerals Ltd - vanadium producer in South Africa - Agrees to a further extension with London-listed Mustang Energy PLC for the notice date to exercise the backstop on the USD8.0 million convertible loan notes owed. Date is now next Wednesday. Mustang will now have until then to extend the maturity date of the convertible loan notes.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 May 2024 12:10

IN BRIEF: Genedrive completes placing portion of GBP6 million raise

Genedrive PLC - Manchester-based pharmacogenetic testing - Completes placing of 138.8 million new shares at 1.5 pence each, raising GBP2.1 million. The placing is part of an overall equity raise being run by Peel Hunt LLP. Late Thursday, Genedrive had said it will try to raise a minimum of GBP6.0 million, including offers to retail investors. If that minimum is not reached, then only the firm placing will go ahead. The placing and retail offer prices will be the same and represent a more than 50% discount to Genedrive's closing price on Thursday. The placing shares will almost double Genedrive's total, and the retail offers could see another 376.4 million new shares issued. It expects to call a general meeting for May 31 to approve the share issue.

Read more
10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
10 May 2024 07:00

IN BRIEF: Genedrive aims to raise at least GBP6 million in share offer

Genedrive PLC - Manchester-based pharmacogenetic testing company - Seeks to raise a minimum of GBP6.0 million from an offer of new shares at 1.5 pence each. The announcement is made after the London market close on Thursday, and the price represents a more than 50% discount to Genedrive's closing price. The equity raise will be split into a firm placing of shares for GBP2.5 million, an offer to new and existing retail investors via the REX platform for GBP3.5 million, and an open offer to existing shareholders for GBP2.1 million. Genedrive says that if the GBP6.0 million minimum target is not reached, then only the firm placing will go ahead. The share sale is being run by broker Peel Hunt LLP.

Read more
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
28 Mar 2024 14:35

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2024 14:27

Genedrive receives R&D tax credit, plans fundraise

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Read more
15 Mar 2024 13:50

Genedrive down as plans equity raise despite GBP800,000 tax credit

(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.

Read more
19 Feb 2024 18:57

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
19 Feb 2024 10:56

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
2 Jan 2024 14:39

Genedrive confirms £0.6m equity prepayment drawdown

(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.